Form 8-K - Current report:
SEC Accession No. 0001753926-25-000604
Filing Date
2025-04-09
Accepted
2025-04-09 17:06:44
Documents
16
Period of Report
2025-04-09
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K g084766_8k.htm   iXBRL 8-K 35368
2 EX-3.1 g084766_ex03-01.htm EX-3.1 16886
3 GRAPHIC ex0301_image1.jpg GRAPHIC 16288
4 GRAPHIC ex0301_image2.jpg GRAPHIC 7179
  Complete submission text file 0001753926-25-000604.txt   267724

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE lipo-20250409.xsd EX-101.SCH 3011
6 XBRL LABEL FILE lipo-20250409_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE lipo-20250409_pre.xml EX-101.PRE 24162
18 EXTRACTED XBRL INSTANCE DOCUMENT g084766_8k_htm.xml XML 3966
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41575 | Film No.: 25825841
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)